1 / 17

RESTORATIVE PLASTICITY AT CORTICOSTRIATAL EXCITATORY SYNAPSES

RESTORATIVE PLASTICITY AT CORTICOSTRIATAL EXCITATORY SYNAPSES. A project funded by the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement n° 222918. Graph and Illustrations: The Visual Agency. PARKINSON’S DISEASE (PD) is one of the most common

sibyl
Télécharger la présentation

RESTORATIVE PLASTICITY AT CORTICOSTRIATAL EXCITATORY SYNAPSES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RESTORATIVE PLASTICITY AT CORTICOSTRIATAL EXCITATORY SYNAPSES A project funded by the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement n° 222918 Graph and Illustrations: The Visual Agency

  2. PARKINSON’S DISEASE (PD) is one of the most common chronic progressive neurodegenerative diseases has a prevalence of 1.2 million people in Europe and an annual cost of 11 billion Euros, being one of the 12 most costly brain diseases in Europe Di Luca M, Baker M, Corradetti R, Kettenmann H, Mendlewicz J, Olesen J, Ragan I, Westphal M. Eur J Neurosci. 2011

  3. COST OF DISORDERS OF THE BRAIN IN EUROPE Estimates in 2004 Estimates in 2010 (1) Referred to as “effective disorders” in 2005, (2) includes only incident cases in 2010, (3) weighted mean from all countries and diagnoses (5) including also persons with zero costs, (6) excluding indirect costs, (7) excluding PTSD. European Neuropsychopharmacology (2011) 21, 718-779

  4. COST OF DISORDERS OF THE BRAIN IN EUROPE Estimates in 2004 Estimates in 2010 The cost of brain diseases in Europe has been estimated 798 billion euros (The economic cost of brain disorders in Europe. Olesen et al, Eur J Neurol. 2012) (1) Referred to as “effective disorders” in 2005, (2) includes only incident cases in 2010, (3) weighted mean from all countries and diagnoses (5) including also persons with zero costs, (6) excluding indirect costs, (7) excluding PTSD. European Neuropsychopharmacology (2011) 21, 718-779

  5. WHAT DO WE ASK TO RESEARCH? A strong translational character: Understanding the brain functioning at molecular, cellular and system level is essential to unravel pathogenesis of brain disease How to impact on disease onset and progression, to effectively help those citizens LEAVING WITH PD

  6. A spine is moving! A confocal microscopy analysis

  7. IN VITRO... Pure Striatum Striatum co-cultured with cortex

  8. IN VIVO... AAV α-synuclein model of PD: progressive neurodegeneration

  9. 3 NOVEL HYPOTHESES TO CURE

  10. METABOTROPIC GLUTAMATE RECEPTOR TYPE 5 (mGluR5) AS A TARGET FOR THE TREATMENT OF L-DOPA-INDUCED DYSKINESIA

  11. TAT NR2A C-tail TAT-2A TAT-2A(-SDV) Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg - Lys-Met-Pro-Ser-Ile-Glu-Ser-Asp-Val Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg - Lys-Met-Pro-Ser-Ile-Glu SYNAPTIC LOCALIZATOR OF NR2A SUBUNIT IN CHRONIC L-DOPA TREATED ANIMALS MODULATES DYSKINETIC MOTOR BEHAVIOUR

  12. REBALANCE OF STRIATAL NMDA/AMPA RECEPTOR RATIO UNDERLIES THE REDUCED EMERGENCE OF DYSKINESIA DURING D2-LIKE DOPAMINE AGONIST TREATMENT

  13. THE REPLACES CONSORTIUM Monica Di LucaUniversity of Milano - ItalyPaolo CalabresiFondazione Santa Lucia - ItalyEckart GundelfingerLeibniz Institute for Neurobiology - GermayEtienne HirschINSERM - FranceStephen DunnettCardiff University - United KingdomAnders BjorklundLund University - LU SwedenJose ObesoUniversity of Navarra - SpainJohn RothwellUniversity College London - UCL United KingdomLaurent Fagni Centre National de la Recherche Scientifique - FranceMary BakerEuropean Parkinson's Disease Association Carla FinocchiaroCF consulting Srl - Italy Graph and Illustrations: The Visual Agency THANK YOU

More Related